Side effects of treatment in patients with hepatitis C - implications for nurse specialist practice

Australian Journal of Advanced Nursing

Volumn 27, Issue 2, 2009, Pages 70-77

  Grogan, Anne ^a   Timmins, Fiona ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Hepatitis C; Needs; Nurse specialist; Nursing; Symptoms

Indexed keywords

EID: 72449200212     PISSN: 08130531     EISSN: 14474328     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Armstrong, P. 1999. The role of the clinical nurse specialist. Nursing Standard, 13(16):40-42.
2. Bonaccorso, S., Marino, V., Puzella, J., Pasquini, M., Biondi, M. and Astini, M. 2002. Combination interferon alfa-2b/ribavirin therapy for the treatment of hepatitis C: nursing implications. Gastroenterology Nursing, 23(2):55-62
3. Bousfield, C. 1997. A phenomenological investigation into the role of the clinical nurse specialist. Journal of Advanced Nursing, 25:245-256.
4. Brennan, A., Thornton, L., Connell, J., O'Neill, W. and O'Riordan, J. 2004. Epidemiology of Hepatitis C infection in Ireland. EPI-INSIGHT, 5(5):2-4.
5. Consultative Council on Hepatitis C. 2005. A Review of Health Services for Persons who Contracted Hepatitis C through the Administration within the State of Blood and Blood Products. Dublin: Brunswick Press Limited.
6. Cormier, M. 2005. The role of hepatitis C support groups. Gasteroenterology Nursing, 28(Suppl. 1):4-9.
7. Cornberg, M., Wedemeyer, H. and Manns, M. 2002. Treatment of chronic hepatitis C with pegylated interferon and ribavirin. Current Gastroenterology Report, 4(1):23-30.
8. Ewart, A., Harrison, L., Joyner, B. and Safe, A. 2004. Providing treatment for hepatitis C in an Australian district centre. Postgraduate Medical Journal, 80(941):180-182.
9. Fletcher, S. 2003. Sexual transmission of hepatitis C and early intervention. Journal of the Association of Nurses in AIDS Care, 14(5 Suppl. 1):87-94.
10. Fried, M.W. 2002. Side effects of therapy of hepatitis C and their management. Hepatology, 36(5 Suppl. 1):237-244.
11. th Edition. Oxford: Blackwell Publishing.
12. Glacken, M., Coates, V., Kernohan, G. and Hegarty, J. 2003. The experience of fatigue for people living with hepatitis C. Journal of Clinical Nursing, 12(2):244-252.
13. Glacken, M., Kernohan, G., and Coates, V. 2001. Diagnosed with hepatitis C: a descriptive exploratory study. International Journal of Nursing Studies, 38(1):107-116.
14. Hayter, M. 2006. Nurses' discourse in contraceptive prescribing: an analysis using Foucault's 'procedures of exclusion' Journal of Advanced Nursing, 58(4):358-367.
15. Health Protection Surveillance Centre. 2006. Quarterly Report Hepatitis C Notifications Q4 2006. Dublin: Health Service Executive.
16. Langford, C.P.H., Bowsher, J., Maloney, J.P. and Lillis, P.P. 1997. Social support: a conceptual analysis. Journal of Advanced Nursing, 25(1):95-100.
17. Lawrence, S.P. 2000. Advances in the treatment of hepatitis C. Advances in Internal Medicine, 45(107):65-105.
18. Leone, N.E. 2002. The role of nursing in managing treatment-associated adverse effects in patients with hepatitis C. Gastroenterology Nursing, 25(5):201-203.
19. Levine, C.D. and Ghalib, R.H. 2005. Assessment of the patient who failed treatment for chronic hepatitis C. Gastroenterology Nursing, 28(Suppl. 1):24-30.
20. Maddrey, W. 1999. Safety of combination interferon alfa-2b/ ribavirin therapy in chronic hepatitis C-relapsed and treatment-naïve patients. Seminars in Liver Disease, 19(Suppl.1):67-75.
21. McHutchinson, J., Manns, M., Patel, K., Poynard, T., Lindsay, K.L. and Trepo, C. 2002. Adherence to combination therapy enhances sustained response in genotype-1 infected patients with chronic hepatitis C. Gastroenterology, 123(4):1061-1069.
22. Mulhall, B.P. and Younossi, Z. 2005. Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C. Journal of Clinical Gastroenterology, 39(1 Suppl.):S23-27.
23. Pallant, J. 2002. SPSS Survival Guide: A Step by Step Guide to Data Analysis Using SPSS for Windows. Buckingham: Open University Press.
24. Poynard, T., McHutchinson, J., Manns, M., Trepo, C., Lindsay, K. and Goodman, Z. 2002. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology, 122(5):1303-1313.
25. Rhoads, J. 2003. Natural history and epidemiology of hepatitis C. Journal of the Association of Nurses in AIDS Care, 14(5):18-25.
26. Seyam, M.S., Freshwater, D.A., O'Donnell, K. and Mutimer, D.J. 2005. Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C. Journal of Viral Hepatitis 12(5):531-535.
27. Shiffman, M.L., Hoffman, C.M., Contos, M.J., Luketic, V.A., Sanyal, A.J., and Sterling, R.K. 1999. A randomised, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology, 117(5):1164-1172.
28. Tarkka, M.J., Paavilainen, E., Lehti, K., and Astedt-Kurki, P. 2003. In-hospital social support for families of heart patients. Journal of Clinical Nursing 12(5): 736-743.
29. Temple-Smith, M., Gifford, S. and Stoove, M. 2004. The lived experience of men and women with hepatitis C: implications for support needs and health information. Australian Health Review, 27(2): 46-56.
30. Webb, A. and Norton, M. 2004. Clinical assessment of symptom-focused health-related quality of life in HIV/AIDS. Journal of the Association of Nurses in AIDS Care, 15(2):66-81.
31. Zic, I. 2005. Peg interferon alpha/ribavirin combination therapy for the treatment of hepatitis C infection. Gastroenterology Nursing, 28(4):317-328.
32. Zucker, D.M. and Miller, B.W. 2001. Assessment of side effects in patients with chronic hepatitis C receiving combination therapy. Gastroenterology Nursing, 24(4):192-196.